Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter calls spin-off company Edwards Lifesciences:

This article was originally published in Clinica

Executive Summary

Baxter is to call the newly formed cardiovascular company - expected to be spun off from Baxter in the first half of 2000 - Edwards Lifesciences (see Clinica No 867, p 1). Baxter's vice-president, Michael Mussallem, will be the company's CEO and chairman. The company is to be named after Miles Edwards, the man who co-invented the first commercially available artificial heart valve. Edwards, which will have annual sales of nearly $1 billion, will be based in Irvine, California and will employ around 5,000 people worldwide.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073053

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel